一种多功能纳米辅助剂将与Toll-Like 9激动剂合起来,刺激强大的先天性和自适应性抗瘤免疫力
Zhongjie Liu1,2, Shu Li1, Yang Xiao1
1College of Biomedical Engineering, Sichuan University, Chengdu, 610064, China.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
|September 11, 2024
概括
(Mn2+) 增强了Toll-like 9激动剂 (CpG),通过激活免疫通路来增强抗瘤免疫力. 自组装的纳米辅助剂MPN/CpG有效抑制瘤生长,并重塑瘤微环境.
科学领域:
- 免疫学 免疫学 免疫学
- 纳米技术 纳米技术
- 在瘤学瘤学.
背景情况:
- 由于抗瘤免疫激活不足,Toll-like 9激动剂 (CpG) 作为瘤免疫治疗辅助剂的有效性有限.
- 研究了营养金属离子,以提高CpG辅助剂的疗效.
研究的目的:
- 为了识别增强CpG介导免疫激活的金属离子.
- 开发一种新的纳米辅助剂 (MPN/CpG) 来改善瘤免疫疗法.
- 在临床前瘤模型中评估MPN/CpG的疗效.
主要方法:
- 选常见的营养金属离子 (Mn2+,Cu2+,Ca2+,Mg2+,Zn2+,Fe3+,Al3+) 来增强CPG活动.
- (Mn2+) 和CpG与甲基酸盐 (EGCG) 自组合成纳米辅助剂 (MPN/CpG).
- 使用B16黑色素瘤携带的小鼠模型进行体内研究,以评估瘤抑制,瘤微环境调节和免疫反应.
主要成果:
- 2+被确定为CpG的关键增强剂,增强了用于免疫激活的STING-NF-κB通路.
- 局部输送的MPN/CpG抑制了瘤生长,将M2瘤相关巨细胞 (TAMs) 再极化到M1,并增加了CD8+/CD4+ T淋巴细胞和树突细胞 (DC) 透.
- 与自由CpG相比,MPN/CpG显示了增强的淋巴结积累,CpG吸收和DC激活,诱导了强大的抗原特异性CD8+T细胞和幽默免疫力.
- 在预防模型中,用OVA抗原接种MPN/CpG疫苗显著延迟了黑色素瘤的生长,并延长了生存时间.
结论:
- MPN/CpG是一种强大的纳米辅助剂,可增强先天性和适应性抗瘤免疫力.
- 纳米辅助剂有效地重塑瘤微环境,促进抗瘤反应.
- 作为癌症免疫治疗的多功能平台,MPN/CpG具有显著的潜力.
更多相关视频
11:07Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination
Published on: April 29, 2015
13.2K
09:51Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling
Published on: July 26, 2017
12.4K
相关概念视频
Antigens Involved in Adaptive Immunity
474
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
Complete Antigens
Complete antigens possess both immunogenicity and...
474
Tumor Immunotherapy
491
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
491
Antigen Processing Pathways
957
MHC molecules are key players in the immune response, enabling T cells to recognize and respond to specific antigens. They are present on the surface of all nucleated cells in the body and are instrumental in presenting antigens to T cells and activating them. T cells recognize the MHC-antigen complex and initiate an immune response. MHC class I and MHC class II are two main types of MHC molecules, each associated with a distinct antigen processing pathway.
MHC Class I: Presenting Endogenous...
MHC Class I: Presenting Endogenous...
957
Cytotoxic T Cells-mediated Immune Response
859
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
859
Cell-mediated Immune Responses
67.8K
Overview
67.8K
T Cell Activation and Clonal Selection
688
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
688
